Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam administration mode during anesthesia induction in gynecologic day surgery
ChiCTR2300070710Phase 4Not yet recruiting
- Sponsor
- Weifang People's Hospital
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam (3 arms), sponsored by Weifang People's Hospital. Primary endpoint: Induction success rate of remimazolam. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2300070710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070710.